NSE filing, NSE: SHEEL. Summary written from the filing by ALFA Finder's alert engine.
Sheel Biotech Ltd: key numbers
- Share price
- ₹56.65
- Market cap
- ₹115.3 Cr
- Revenue (annual)
- ₹110.0 Cr
- Net profit (annual)
- ₹11.76 Cr
- P/E (TTM)
- 9.8×Sector 45.2×
- Promoter holding
- 72.31%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sheel Biotech Ltd
All →Sheel Biotech Other Announcement
Sheel Biotech Limited has clarified that the Corporate Governance Report is not applicable to the company as it is listed on the SME platform.
Sheel Biotech Bags ₹4.54 Cr Order from Department of Agriculture, Government of Himachal Pradesh
Sheel Biotech won a Rs.4.54 Crore award from Himachal Pradesh's Agriculture Department. The project establishes a blueberry farm and tissue culture laboratory.
- Value
- ₹4.54 Cr
- From
- Department of Agriculture, Government of Himachal Pradesh
Sheel Biotech Annual General Meeting
Sheel Biotech Limited held its 35th Annual General Meeting on September 24, 2026. The meeting covered adoption of financial statements and approval of other ordinary resolutions.
Sheel Biotech Other Announcement
Sheel Biotech intimated that its Statutory Auditor Shyam Sunder Mangla & Co LLP has changed its name to S S Mangla & Co LLP effective 18 December 2025. No change in the auditor appointment itself.
Sheel Biotech Bags ₹14.53 Cr Order
Sheel Biotech Limited has finalised a commercial transaction for its Blueberry project, valued at ₹14.53 Crore. This contract marks a significant business development for the company.
- Value
- ₹14.53 Cr
Sheel Biotech Annual General Meeting
Sheel Biotech Limited scheduled its 35th Annual General Meeting for September 24, 2026. The company also announced the record date and book closure period.
Other legal & regulatory announcements
All →Waaree Energies Legal & Regulatory
Waaree Energies disclosed GPCB's January 2026 closure direction for its Degam solar cell plant, since revoked and extended. Interim compensation and bank guarantees total ₹0.17 Crore.
- Value
- ₹0.17 Cr
5Paisa Capital Legal & Regulatory
5paisa Capital Ltd received a favourable income tax order for AY 2023-24, granting relief of ₹40.03 crore against a total disputed amount of ₹42.90 crore.
- Value
- ₹40.03 Cr
5Paisa Capital Legal & Regulatory
5paisa Capital's appeal against an Income Tax order for A.Y. 2023-24 was partly allowed, granting the company relief of ₹40.03 Crore.
- Value
- ₹42.90 Cr
Max Healthcare Institute Legal & Regulatory
Max Healthcare informed the Exchange that the NCLT hearing regarding petitions against its subsidiary, Kalinga Hospital Ltd., was adjourned to October 30, 2026.
Bank of Baroda Legal & Regulatory
Bank of Baroda clarified media-reported interim applications filed by Dr. BR Shetty in the Bombay High Court. The bank says it has not been served and calls the allegations untested.
Canara Bank Legal & Regulatory
Canara Bank disclosed an RBI penalty of Rs. 7,30,000 over ATM cashout at 73 ATMs in Karnataka and Tamil Nadu. The penalty is the only quantified impact.
- Value
- ₹0.07 Cr